about
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-bas...
Read More
3.64
-0.05
(-1.36%)
1.8M
XNAS Volume
XNAS 12 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Altimmune Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..